WASHINGTON – This year's edition of Transcatheter Cardiovascular Therapeutics (TCT), sponsored by the Cardiovascular Research Foundation (New York) includes the usual sessions on late-breaking clinical trial news as well as sessions on developments in the underlying science, and for firms with products in the pipeline that want to evaluate stent integrity in animal models by means other than histology, one presenter offered data on an imaging technology that can simplify the task. (Medical Device Daily) Read More
